Cancer Research

The new workflow enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development, and precision medicine

Direct in sample sequencing, or DISS, is a high-demand and transformative technology that unlocks library-prep free research possibilities across a variety of new use cases

New xGen™ hybridization and wash offering is poised to revolutionize targeted next generation sequencing workflows

Results from the first cohort of the AURORAX 087A study show the new biomarker-based test provides a more robust basis for making decisions on treatment than scans alone

Study reveals increasing breast cancer rates in US women under 40, with geographic and demographic differences suggesting environmental factors may play a role

Researchers reveal how retinoic acid works against metastatic neuroblastoma, offering new insights into its role in treatment and paving the way for future therapies

The first phase of the Stratified Medicine Paediatrics program shows that ctDNA blood tests can provide crucial insights for targeting treatments and tracking childhood cancer progression

Research program aims to advance precision medicine for children and young people whose cancer has returned

Future breast cancer incidence is projected to increase by 38 percent, and mortality by 68 percent, by 2050

OKN4395 is the first compound to be developed using K1.0, Owkin’s AI-powered operating system